Industry & Business

Takeda to Invest €25 Million at Grange Castle Site in Dublin

 Breaking News
  • Fine Grain invests €35m in Limerick office scheme for 400 staff Fine Grain Property, an Irish-Singaporean commercial property vehicle, is investing €35 million in a new office development for 400 staff at a Limerick business park used by IDA Ireland to attract technology multinationals. The new four-storey development at the IDA National Technology Park in Plassey, 6km from Limerick city centre, will take 12 months to construct, Fine Grain [...]...
  • International Appetite Fed at First Birmingham Brexit Event With so many questions addressed at the first in a series of dedicated Brexit Seminars held in Birmingham, interest amongst its international delegation remains high, with the second Brexit Seminar planned for Wednesday 27th June 2018.   Sectors and countries represented at February’s event encompassed food businesses and non-food importers, Embassies, logistics providers and consultants from the [...]...
  • TSM’s Shane O’Callaghan: ‘The key to IIoT is to keep it beautifully simple’ The rise of industry 4.0 and the industrial internet of things presents lots of unexpected business opportunities, says TSM Control Systems’ Shane O’Callaghan. Shane O’Callaghan is business unit leader of Insight at TSM Control Systems. He joined the company in 2008 as a business analyst and then became sales manager for Europe. TSM Control Systems was founded in [...]...
  • Fine Grain Property acquires 60,000 square feet office development in Cork Airport Business Park New Year, new acquisition! Fine Grain Property is delighted to announce it has acquired a 60,000 square feet office development in Cork Airport Business Park. Plans are already afoot to carry out some important improvements to the Building that will benefit its existing tenants, including Aviva, Aon Hewitt, JLT and Genesis. In addition, a significant [...]...
  • Irish Technology Sector Has Overtaken Agriculture With 130,000 people now employed, the technology sector has overtaken agriculture as Ireland’s largest industry, according to Ken Finnegan (pictured above), formerly Chief Technology and Research Advisor for IDA Technology Ireland and now Director of Technology & Innovation for the about to be opened Harbour Innovation Campus at Dún Laoghaire. About 15,000 of these tech [...]...

Takeda to Invest €25 Million at Grange Castle Site in Dublin

Takeda to Invest €25 Million at Grange Castle Site in Dublin
March 05
11:57 2018

Takeda Pharmaceutical Company is to create up to 70 new jobs and invest €25 million in the construction of a new regenerative medicine facility at its site in Grange Castle. The investment by Takeda will expand their Grange Castle site’s existing footprint, with the construction of a new standalone modular cell therapy facility dedicated to manufacturing a novel stem cell therapy. The investment will also create 70 temporary construction jobs.

The facility will be in commercial operation by 2021. This investment is supported by the Irish Government through IDA Ireland.

The largest pharmaceutical company in Japan, Takeda first set up operations in Ireland in 1997 manufacturing products for global markets. In 2002 Takeda chose Dublin as the location for its first active pharmaceutical ingredient (API) facility outside of Japan. In 2017 Takeda also announced a €40 million investment in the construction of a stand-alone production facility for the manufacture of part of their Oncology portfolio at Grange Castle.

Welcoming the announcement Pat Breen TD, Minister of State at the Department of Enterprise and Innovation, said: “The pharma industry makes a huge contribution to the Irish economy in terms of jobs and exports, and is one of the fastest growing sectors. Takeda’s decision to invest in Ireland is a great win and vote of confidence in Ireland and it builds on our ongoing expansion of the sector here. I’m delighted that this investment will bring a further 70 jobs to the company’s existing Clondalkin facility.”

Paul Keogh, Plant Director at Takeda Ireland Grange Castle, said that the additional investment in Ireland demonstrates the confidence and commitment Takeda has in its Irish operation. “To be chosen as the first site to introduce this new technology platform to our manufacturing network is very exciting. The nature of this product and its process will bring us closer to the patient than ever before which is a responsibility that we take very seriously. We have a great team here in Ireland and are committed to continuing to put patients first through the timely manufacture and supply of high quality products from our site. The roles being created are in the areas of quality, manufacturing and engineering.”

Martin Shanahan, CEO of IDA Ireland, said: “Ireland is a globally recognised centre of excellence in Life sciences due to the country’s strong regulatory track record and talent availability. The investment by Takeda demonstrates their continued commitment to Ireland.”

About Author



Related Articles

New Subscriber

Subscribe Here


National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories

Upcoming Events

  • No upcoming events
AEC v1.0.4